Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Nat Med. 2010 Jan 17;16(2):232. doi: 10.1038/nm.2080

Table 3.

Long-term Persistence in Patients 2 and 6: Percent Peripheral Blood Cells Derived from the Expanded Cell Graft

% Expanded Donor* Patient 2 Day 240 Patient 6 Day 180
CD33 0 25
CD14 12 31
CD56 15 50
CD19 5 66
CD3 0 0
*

No host cells were observed (level of detection 1–5%).